Deregulation of IGF signaling has been described in several cancer types, including both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) [6], and high expression of IGF-1R in NSCLC has been reported [7, 8]. Here, IGF1R is linked to cancer.